Evaluation of the AGE/sRAGE Axis in Patients with Multiple Myeloma

Glycative stress influences tumor progression. The aim of the present study was to evaluate the advanced glycation end products/soluble receptor of advanced glycation end products (AGE/sRAGE) axis in patients with multiple myeloma (MM). Blood samples were taken from 19 patients affected by MM and fr...

Full description

Bibliographic Details
Published in:	Antioxidants
Main Authors:	Alessandro Allegra, Caterina Musolino, Elisabetta Pace, Vanessa Innao, Eleonora Di Salvo, Maria Ferraro, Marco Casciaro, Giovanna Spatari, Gennaro Tartarisco, Andrea Gaetano Allegra, Sebastiano Gangemi
Format:	Article
Language:	English
Published:	MDPI AG 2019-03-01
Subjects:	advanced glycation end products soluble receptor of advanced glycation end products oxidation multiple myeloma
Online Access:	http://www.mdpi.com/2076-3921/8/3/55

Similar Items

Obesity and Comorbidity: Could Simultaneous Targeting of esRAGE and sRAGE Be the Panacea?
by: Chinedum Eleazu, et al.
Published: (2019-06-01)

High BAL sRAGE is Associated with Low Serum Eosinophils and IgE in Children with Asthma
by: Jason T. Patregnani, et al.
Published: (2020-08-01)

Corrigendum: Obesity and Comorbidity: Could Simultaneous Targeting of esRAGE and sRAGE Be the Panacea?
by: Chinedum Eleazu, et al.
Published: (2019-08-01)

The Anti-AGEing and RAGEing Potential of Isothiocyanates
by: Bradley A. Krisanits, et al.
Published: (2024-12-01)

Advanced Glycation End-Products (AGEs) and Their Soluble Receptor (sRAGE) in Women Suffering from Systemic Lupus Erythematosus (SLE)
by: Agnieszka Nowak, et al.
Published: (2021-12-01)

Ginseng improves cognitive deficit via the RAGE/NF-κB pathway in advanced glycation end product-induced rats
by: Xiaobin Tan, et al.
Published: (2015-04-01)

The Assessment of Serum Concentrations of AGEs and Their Soluble Receptor (sRAGE) in Multiple Sclerosis Patients
by: Aleksandra Damasiewicz-Bodzek, et al.
Published: (2021-07-01)

Targeting the AGEs-RAGE axis: pathogenic mechanisms and therapeutic interventions in diabetic wound healing
by: Haohui Lin, et al.
Published: (2025-09-01)

New Glycotoxin Inhibitor from <i>Sesuvium sesuvioides</i> Mitigates Symptoms of Insulin Resistance and Diabetes by Suppressing AGE-RAGE Axis in Skeletal Muscle
by: Safina Ghaffar, et al.
Published: (2024-08-01)

The impact of polytrauma on sRAGE levels: evidence and statistical analysis of temporal variations
by: Lukas L. Negrin, et al.
Published: (2019-03-01)

The Role of Advanced Glycation End Products in Diabetic Vascular Complications
by: Sang Youl Rhee, et al.
Published: (2018-05-01)

RAGE Knockout Mitigates Diet-Induced Obesity and Metabolic Disruption
by: Isabelle L. Palmer, et al.
Published: (2025-08-01)

Protein glycoxidation in neuropsychiatric disorders—from basic research to clinical practice
by: Wiktor Orlof, et al.
Published: (2026-07-01)

Explore the mechanism of puerarin to improve diabetic peripheral neuropathy in rats based on AGEs/RAGE signaling pathway
by: HAO Lu, et al.
Published: (2025-05-01)

RAGE is a critical factor of sex-based differences in age-induced kidney damage
by: Seerat Bajwa, et al.
Published: (2023-03-01)

Clinical Factors and Biomarkers Associated with Depressive Disorders in Older Patients Affected by Chronic Kidney Disease (CKD): Does the Advanced Glycation End Products (AGEs)/RAGE (Receptor for AGEs) System Play Any Role?
by: Massimiliano Buoli, et al.
Published: (2024-07-01)

Expression of advanced glycation end products and receptors in gingival tissues of patients with noninsulin-dependent diabetes mellitus-associated periodontitis
by: Ya-Han Chang, et al.
Published: (2023-04-01)

Research Progress on Advanced Glycation End Products in Aging-related Diseases
by: Yanling Shen, et al.
Published: (2024-07-01)

Evaluation of the Impact of Advanced Glycation End-Products on Peripheral Neuropathy Outcomes in Type 2 Diabetes
by: Indumathi Singh, et al.
Published: (2024-11-01)

Glycation: A Connecting Link Between Diabetes and COVID-19
by: Sneha B. Bansode, et al.
Published: (2022-01-01)

Humoral factors in the formation of neuroosteoarthropathy in type 2 diabetes mellitus
by: M. M. Kalandiya, et al.
Published: (2023-12-01)

Fructose-mediated AGE-RAGE axis: approaches for mild modulation
by: Halyna Semchyshyn
Published: (2024-12-01)

Antiglycation potential of commercial available extracts of two Indian medicinal plants: Pterocarpus marsupium and Artocarpus lakoocha using advanced glycation end products (AGE) competitive fluorescence assay
by: Alpana Pande, et al.
Published: (2021-01-01)

Sulforaphane Inhibits MGO-AGE-Mediated Neuroinflammation by Suppressing NF-κB, MAPK, and AGE–RAGE Signaling Pathways in Microglial Cells
by: Lalita Subedi, et al.
Published: (2020-08-01)

Glyoxal-Lysine Dimer, an Advanced Glycation End Product, Induces Oxidative Damage and Inflammatory Response by Interacting with RAGE
by: Hee-Weon Lee, et al.
Published: (2021-09-01)

sRAGE levels are decreased in plasma and sputum of COPD secondary to biomass-burning smoke and tobacco smoking: Differences according to the rs3134940 AGER variant
by: Ingrid Fricke-Galindo, et al.
Published: (2024-04-01)

Receptor of advanced glycation end products and cardiovascular risk in elderly with type 2 diabetes mellitus
by: Claudia Borsa, et al.
Published: (2018-02-01)

Assessment of Oral Glycine and Lysine Therapy on Receptor for Advanced Glycation End Products and Transforming Growth Factor Beta Expression in the Kidney of Streptozotocin-Induced Diabetic Rats in Comparison with Normal Rats
by: Somayeh Sadat Heidary, et al.
Published: (2014-01-01)

Pathological Role of Receptor for Advanced Glycation End Products in Calcified Aortic Valve Stenosis
by: Kosuke Saku, et al.
Published: (2020-07-01)

Evaluation of circulating sRAGE in osteoporosis according to BMI, adipokines and fracture risk: a pilot observational study
by: Emanuela Galliera, et al.
Published: (2017-06-01)

AGEs-RAGE manipulates tumor intrinsic pERK/Sp1/IL6 pathway and reprograms macrophage to promote intrahepatic cholangiocarcinoma progression
by: Juan Zhang, et al.
Published: (2025-10-01)

Reduced sRAGE Production and ADAM10 Gene Expression in Peripheral Blood Samples of Diabetic Nephropathy Patients
by: Claire Gabriella Dias, et al.
Published: (2022-01-01)

Polymorphism of the RAGE Affects the Serum Inflammatory Levels and Risk of Ischemic Stroke in a Chinese Population
by: XiaoPing Cui, et al.
Published: (2013-10-01)

Role of rs 1800625 and 63bp deletion RAGE Gene Polymorphisms in Hepatocellular Carcinoma Progression
by: Mariam Mohamed, et al.
Published: (2021-10-01)

Glycation of Nail Proteins as a Risk Factor for Onychomycosis. Comment on Gupta et al. Diabetic Foot and Fungal Infections: Etiology and Management from a Dermatologic Perspective. <i>J. Fungi</i> 2024, <i>10</i>, 577
by: Terenzio Cosio, et al.
Published: (2025-01-01)

Magnolol ameliorates the accumulation of reactive oxidative stress and inflammation in diabetic periodontitis
by: Chia-Ming Liu, et al.
Published: (2021-07-01)

Receptor for advanced glycation end products (RAGE) as a novel biomarker for differentiating drowning from postmortem submersion
by: mariem shafek Keryakous, et al.
Published: (2023-01-01)

Phosphorylated Alpha-Synuclein and Carboxymethyllysine in the Epidermis of Type 2 Diabetes Patients: Preliminary Observations
by: Bernard Kordas, et al.
Published: (2026-05-01)

The Protective Effect of Brazilian Propolis against Glycation Stress in Mouse Skeletal Muscle
by: Tatsuro Egawa, et al.
Published: (2019-09-01)

The RAGE Axis: A Relevant Inflammatory Hub in Human Diseases
by: Armando Rojas, et al.
Published: (2024-03-01)